Annual Total Liabilities:
$70.76M+$22.36M(+46.20%)Summary
- As of today, VRDN annual total liabilities is $70.76 million, with the most recent change of +$22.36 million (+46.20%) on December 31, 2024.
- During the last 3 years, VRDN annual total liabilities has risen by +$54.77 million (+342.47%).
- VRDN annual total liabilities is now at all-time high.
Performance
VRDN Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Liabilities:
$67.16M+$10.65M(+18.84%)Summary
- As of today, VRDN quarterly total liabilities is $67.16 million, with the most recent change of +$10.65 million (+18.84%) on June 30, 2025.
- Over the past year, VRDN quarterly total liabilities has increased by +$10.83 million (+19.23%).
- VRDN quarterly total liabilities is now -5.10% below its all-time high of $70.76 million, reached on December 31, 2024.
Performance
VRDN Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
VRDN Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +46.2% | +19.2% |
| 3Y3 Years | +342.5% | +140.6% |
| 5Y5 Years | - | +445.4% |
VRDN Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +342.5% | -5.1% | +88.6% |
| 5Y | 5-Year | at high | +530.8% | -5.1% | +498.6% |
| All-Time | All-Time | at high | +3272.9% | -5.1% | +3266.0% |
VRDN Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $67.16M(+18.8%) |
| Mar 2025 | - | $56.51M(-20.1%) |
| Dec 2024 | $70.76M(+46.2%) | $70.76M(+9.9%) |
| Sep 2024 | - | $64.40M(+14.3%) |
| Jun 2024 | - | $56.33M(+17.7%) |
| Mar 2024 | - | $47.85M(-1.1%) |
| Dec 2023 | $48.40M(+20.9%) | $48.40M(+7.1%) |
| Sep 2023 | - | $45.18M(+26.9%) |
| Jun 2023 | - | $35.61M(-1.3%) |
| Mar 2023 | - | $36.09M(-9.8%) |
| Dec 2022 | $40.03M(+150.3%) | $40.03M(+43.4%) |
| Jun 2022 | - | $27.92M(+69.0%) |
| Mar 2022 | - | $16.52M(+3.3%) |
| Dec 2021 | $15.99M(+42.6%) | $15.99M(-3.7%) |
| Sep 2021 | - | $16.61M(-13.9%) |
| Jun 2021 | - | $19.29M(+14.6%) |
| Mar 2021 | - | $16.83M(+50.1%) |
| Dec 2020 | $11.22M | $11.22M(-4.9%) |
| Sep 2020 | - | $11.79M(-4.2%) |
| Jun 2020 | - | $12.31M(+2.2%) |
| Mar 2020 | - | $12.05M(-16.9%) |
| Dec 2019 | - | $14.51M(-7.3%) |
| Sep 2019 | - | $15.64M(+1.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $15.35M(+9.7%) |
| Mar 2019 | - | $13.99M(-5.5%) |
| Dec 2018 | $14.80M(+6.0%) | $14.80M(-6.5%) |
| Sep 2018 | - | $15.84M(+11.4%) |
| Jun 2018 | - | $14.22M(-0.5%) |
| Mar 2018 | - | $14.29M(+2.3%) |
| Dec 2017 | $13.97M(+44.0%) | $13.97M(+72.6%) |
| Sep 2017 | - | $8.10M(-6.8%) |
| Jun 2017 | - | $8.69M(-11.3%) |
| Mar 2017 | - | $9.80M(+1.0%) |
| Dec 2016 | $9.71M(+289.4%) | $9.71M(+239.9%) |
| Sep 2016 | - | $2.85M(+9.6%) |
| Jun 2016 | - | $2.60M(+6.0%) |
| Mar 2016 | - | $2.46M(+13.5%) |
| Dec 2015 | $2.49M(+18.8%) | - |
| Sep 2015 | - | $2.16M(+0.6%) |
| Jun 2015 | - | $2.15M(-17.2%) |
| Mar 2015 | - | $2.60M(+23.8%) |
| Dec 2014 | $2.10M(-92.4%) | $2.10M(+5.2%) |
| Sep 2014 | - | $2.00M(-9.3%) |
| Jun 2014 | - | $2.20M(-92.0%) |
| Dec 2013 | $27.56M(+13.8%) | $27.56M(+13.8%) |
| Dec 2012 | $24.22M | - |
| Dec 2012 | - | $24.22M |
FAQ
- What is Viridian Therapeutics, Inc. annual total liabilities?
- What is the all-time high annual total liabilities for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual total liabilities year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly total liabilities?
- What is the all-time high quarterly total liabilities for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly total liabilities year-on-year change?
What is Viridian Therapeutics, Inc. annual total liabilities?
The current annual total liabilities of VRDN is $70.76M
What is the all-time high annual total liabilities for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual total liabilities is $70.76M
What is Viridian Therapeutics, Inc. annual total liabilities year-on-year change?
Over the past year, VRDN annual total liabilities has changed by +$22.36M (+46.20%)
What is Viridian Therapeutics, Inc. quarterly total liabilities?
The current quarterly total liabilities of VRDN is $67.16M
What is the all-time high quarterly total liabilities for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly total liabilities is $70.76M
What is Viridian Therapeutics, Inc. quarterly total liabilities year-on-year change?
Over the past year, VRDN quarterly total liabilities has changed by +$10.83M (+19.23%)